Febrile Urinary Tract Infection Randomized Short Treatment Trial.
Recruiting
- Conditions
- urinary tarct infection, acute pyelonephritis, urosepsis
- Registration Number
- NL-OMON20802
- Lead Sponsor
- eiden University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
1. Competent patient aged 18 years or above;
2. One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or urgency*; perineal or suprapubic pain; costo-vertebral tenderness or flank pain);
Exclusion Criteria
1. Known allergy to fluoroquinolones;
2. Female patients who are pregnant or lactating;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical cure rate through the 10- to 18-day posttherapy visit. Clinical cure is defined as the resolution of fever and signs and symptoms of UTI.
- Secondary Outcome Measures
Name Time Method This includes microbiological cure rate 10- to 18-day posttherapy, 30- and 90- day overall mortality rate, clinical cure rate 70- to 84- day posttherapy, time to resolution of symptoms, relapse rate of UTI, adverse events or complications, rate of pelvic floor dysfunction as assessed by a standardize questionaire and the occurrence of Clostridium difficile disease.